Structural basis for antibody-mediated neutralization of Lassa virus.
about
Human antibody pieces together the puzzle of the trimeric Lassa virus surface antigen.MBD2 Regulates Th17 Cell Differentiation and Experimental Severe Asthma by Affecting IRF4 Expression.Mutational Analysis of Lassa Virus Glycoprotein Highlights Regions Required for Alpha-Dystroglycan Utilization.Understanding the cryptic nature of Lassa fever in West Africa.The bulky and the sweet: How neutralizing antibodies and glycan receptors compete for virus binding.Epistastic interactions within the Junín virus envelope glycoprotein complex provide an evolutionary barrier to reversion in the live-attenuated Candid#1 vaccine.Lamp1 Increases the Efficiency of Lassa Virus Infection by Promoting Fusion in Less Acidic Endosomal Compartments.Axl can serve as entry factor for Lassa virus depending on the functional glycosylation of dystroglycan.Structures of the prefusion form of measles virus fusion protein in complex with inhibitors.Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever.Baseline mapping of Lassa fever virology, epidemiology and vaccine research and development.A Universal Approach to Optimize the Folding and Stability of Prefusion-Closed HIV-1 Envelope Trimers.Structural analysis of glycoproteins: building N-linked glycans with Coot.Antibodies to the Glycoprotein GP2 Subunit Cross-React between Old and New World Arenaviruses.Vaccine-elicited receptor-binding site antibodies neutralize two New World hemorrhagic fever arenaviruses.Structure of the Lassa virus glycan shield provides a model for immunological resistanceNon-neutralizing antibodies elicited by recombinant Lassa-Rabies vaccine are critical for protection against Lassa fever
P2860
Q33365688-AC2D53C6-1276-46F6-974F-8F99A252A60BQ38624904-8E7B1DA1-994C-4E78-9104-05291FEB7A2EQ38662402-90EDFB23-3D16-474A-948A-9D262B0FBA4BQ40040547-49B65FA4-B6D0-4228-BA36-C64478FC20E5Q41922286-908EE95B-6584-4E4A-9432-20296BEF9A7EQ45325680-C06C060F-A493-4687-B441-2FD91DA12F6FQ47117332-9D46AFD2-A412-4655-BCC4-0D9052046B9CQ47296347-93685903-6C56-42D3-9E33-225D9E1B47EFQ49790503-8BC0D0F0-E435-491D-9F80-C9C6215BF595Q52590886-7430B4ED-38AD-48F4-834A-460143273820Q52723914-0D64DD1B-CFC4-48FD-8C18-9A2734F4C12CQ54237723-F95A7A53-A5EF-49C3-87DF-73DE0751001FQ54946742-655A2993-8610-4A5E-BAED-AC46921C905EQ55306089-87D1DBB4-3AA1-438B-B6A7-B8D2B6A68262Q55434508-7872A691-D7ED-4322-AD80-010CE227426FQ56941600-4AC83618-E34D-4CF4-83B7-D533D83A8B37Q57476548-7818255C-6E87-436C-BA8E-EF0E7B3B7BFE
P2860
Structural basis for antibody-mediated neutralization of Lassa virus.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Structural basis for antibody-mediated neutralization of Lassa virus.
@en
type
label
Structural basis for antibody-mediated neutralization of Lassa virus.
@en
prefLabel
Structural basis for antibody-mediated neutralization of Lassa virus.
@en
P2860
P50
P356
P1433
P1476
Structural basis for antibody-mediated neutralization of Lassa virus.
@en
P2093
James E Robinson
Megan L Heinrich
P2860
P304
P356
10.1126/SCIENCE.AAM7260
P407
P50
P577
2017-06-01T00:00:00Z